Institutional investors purchased a net $5.9 thousand shares of BIOC during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 9.90% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PERKINS CAPITAL MANAGEMENT, INC. Bought 26.5 Thousand shares of Biocept Inc
CAMELOT PORTFOLIOS LLC Bought 10.0 Thousand shares of Biocept Inc
VERITION FUND MANAGEMENT LLC Bought 2.3 Thousand shares of Biocept Inc